EGS Healthcare Capital Partners Mergers and Acquisitions Summary

Private Equity Profile

EGS Healthcare Capital Partners’ most common sectors for investment are medical products (58%) and life science (43%). The Firm’s most common investment types include venture (72%) and buyout (lbo, mbo, mbi) (15%). In total, EGS Healthcare Capital Partners has invested in 4 US states and 2 different countries. Its largest (disclosed) acquisition occurred in 2003 when it acquired Ardais for $34M.

The Firm’s most common exit type is trade sale (43%). EGS Healthcare Capital Partners’ largest (disclosed) exit occurred in 2007 when it sold Cerexa for $480M.

Join Mergr to view EGS Healthcare Capital Partners’ full profile and discover more small private equity firms just like it.

M&A Summary

  • M&A Total Activity14
    • M&A Buy Activity7
    • M&A Sell Activity7
  • Total Sectors Invested 2
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 13

EGS Healthcare Capital Partners LLC

105 Rowayton Avenue, 2nd Floor,
Rowayton, Connecticut 06853
United States
(203) 854-0559
www.egshealthcare.com
mderby@egshealthcare.com

EGS Healthcare Capital Partners is a specialist private equity firm focused on investments in the healthcare sector. Specific areas of interest include biotechnology, specialty pharmaceutical, and medical device companies. EGS typically invests in late-stage private and emerging public companies with promising products. EGS prefers to lead investments with an initial commitment of $5 million per transaction. The Firm generally seeks board representation. EGS Healthcare Partner was formed in 1999 and is based in Rowayton, Connecticut.


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Venture

Geographic Preferences: East US, Midwest US, South US, West US

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size 3 7
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (0.0/yr) # 7 - - - - - 7
vol $52M $52M
Sell (0.0/yr) # 7 - - - - - 7
vol $805M $805M
  14

Most Recent M&A

Company Date Value Type
Anesiva, Inc. 2010-01-15 - Bankruptcy
South San Francisco, California · www.anesiva.com
Jazz Pharmaceuticals PLC 2007-06-01 - IPO
Dublin, Ireland · www.jazzpharma.com
Endius, Inc. 2007-04-20 80M USD Add-on Acquisition
Plainville, Massachusetts · www.endius.com
Cerexa, Inc. 2007-01-01 480M USD Add-on Acquisition
Oakland, California · www.cerexa.com
Peninsula Pharmaceuticals, Inc. 2005-06-30 245M USD Add-on Acquisition
Alameda, California · www.peninsulapharm.com
EKOS Corp. 2005-02-18 - Buyout (LBO, MBO, MBI)
Bothell, Washington · www.ekoscorp.com
Transport Pharmaceuticals, Inc. 2004-10-01 - Venture
Framingham, Massachusetts · www.transportpharma.com
Stereotaxis, Inc. 2004-08-12 - IPO
St. Louis, Missouri · www.stereotaxis.com
Jazz Pharmaceuticals PLC 2004-03-24 - Venture
Dublin, Ireland · www.jazzpharma.com
Anesiva, Inc. 2004-02-01 - PIPE
South San Francisco, California · www.anesiva.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Medical Products - - 4 (57%) 18M (35%)
Life Science - - 3 (43%) 34M (65%)
Total - - 7 $52M

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States - - 6 (86%) 52M (100%)
  Massachusetts - - 3 (43%) 34M (65%)
  Missouri - - 1 (14%) 18M (35%)
  Washington - - 1 (14%) -
  California - - 1 (14%) -
Ireland - - 1 (14%) -
Domestic - - 6 (86%) 52M (100%)
Cross-border - - 1 (14%) -
Total - - 7 $52M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture - - 5 (71%) 52M (100%)
Buyout (LBO, MBO, MBI) - - 1 (14%) -
PIPE - - 1 (14%) -
Total - - 7 $52M

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 3 (43%) 805M (100%)
IPO 2 (29%) -
Bankruptcy 1 (14%) -
Trade Sale 1 (14%) -
Total 7 $805M

Deal Values

buy # Total
< $100M 2 $52M
TOTAL $52M
Largest Ardais Corp.
$34M (2003-03-19)
sell # Total
$100M to $1B 2 $725M
< $100M 1 $80M
TOTAL $805M
Largest Cerexa, Inc.
$480M (2007-01-01)

M&A Connections

Deals %
Exited to
Strategic(s)
100%
3 100%

 Subscribe to unlock this and 152,087
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.9K Private Equity Firms
  • 140K M&A Transactions
  • 148K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.1K M&A Advisors
    (Investment Banks and Law Firms)
  • 41K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.